What Are the Challenges in Using Nanoparticles for Cancer Treatment?
Despite their potential, there are several challenges associated with the use of nanoparticles in cancer treatment:
Biocompatibility: Ensuring that nanoparticles are non-toxic and do not elicit an immune response is crucial. Drug Resistance: Cancer cells may develop resistance to the drugs delivered by nanoparticles, necessitating the development of new strategies. Scalability: Producing nanoparticles on a large scale while maintaining consistency and quality is a significant challenge. Regulatory Hurdles: The approval process for nanomedicines can be complex and time-consuming due to the need for extensive safety and efficacy data.
